💚 October is Liver Cancer Awareness Month. Cholangiocarcinoma (bile duct cancer) is a rare and complex form of liver cancer — but awareness can lead to earlier diagnosis and better outcomes. Swipe ➡️ to learn about risk factors, symptoms, and how the Cholangiocarcinoma

Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage https://t.co/pWwExgNItL

Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma https://t.co/INlcZFYtkA

What are the clinical behaviors and molecular characteristics of extrahepatic cholangiocarcinoma (EHC) and gallbladder cancer (GBC), and what are effective and specific treatment strategies? @JAMAOnc #TIC2025 #Oncology https://t.co/frnpsDFIwe

Paraneoplastic syndromes associated with Cholangiocarcinoma. https://t.co/8D9upzyooN

🎯 3-Year OS Nearly Doubled: ACCORD Trial Delivers! @OncoAlert 🎯 Objective Evaluate if adjuvant camrelizumab + capecitabine + ☢️ ⬆️ outcomes vs. observation after curative 🔪 for extrahepatic cholangiocarcinoma (EHC) & gallbladder cancer (GBC). 🏥 Methods •Design: ACCORD RCT

Hepatic Arterial Infusion Pump Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma 🔎PUMP-2 Trial @JCO_ASCO https://t.co/EMwfTeeo8Z 👉48 pts HAIP floxuridine + CTx 👉PR: 44%; DCR: 84% 👉1-year OS: 80.0% 🧐strong signal, interesting opportunity for downstaging,

Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.

SUBATHON GOALS FOR A GOOD CAUSE! 50% of all October revenue will go towards the Cholangiocarcinoma Foundation Australia! ♡ Can't wait to see you all next week to officially reveal 3 new models, all new emotes, overlays, alerts, and more! 🎨@/alte_27 #vtuber #vtuberdebut

Right hemi-hepatectomy plus total caudate lobectomy for perihilar #cholangiocarcinoma

💚 October is Liver Cancer Awareness Month 💚 The Cholangiocarcinoma Foundation stands with the International Liver Cancer Movement in a global effort to raise awareness of liver cancer, with a focus on cholangiocarcinoma (bile duct cancer), a rare but aggressive form of liver

A rare diagnosis to attract- ❄️Thyroid like cholangiocarcinoma with LCNEC ❄️ @archibhat3 @anjuthevirgo @IHC_guy @PathTweetAward @JaredAhrendsen @adi_agnihotri @kriyer68 @CraigHorbinski @DanGrahamMD @Kenny92954457 @DrCycloPath @DrGeeONE @Vik_deshpandeMD @MariamHHameed1 🎯🔬🙇🙇‍♀️💭

PLEASE PRAY FOR MY WIFE AND I TODAY- AT 9:30 AM We meet with my surgeon about a major 6–8 hour Whipple surgery for my cholangiocarcinoma. This growth was discovered after my recent three-day hospital stay. We need God’s wisdom and strength today. Thank you for lifting us up in

Review Article Immunogenomics of cholangiocarcinoma Gehl et al. #LiverX https://t.co/xl8d2AlvSs

💜 Did you know? 💜 Primary liver cancer is one of the fastest-growing cancers worldwide. The two most common types are: 👉 Hepatocellular carcinoma (HCC) – 85–90% of cases 👉 Cholangiocarcinoma (CCA / bile duct cancer) – about 15% of cases Early detection and awareness save

🔥topics in surg onc: HAIP for intrahepatic cholangiocarcinoma by @FlavioRochaMD #ACSCC25 ⛽️PUMP-II trial 🇳🇱 - good response & favourable survival vs historical controls Ongoing HELIX2 trial

Peripheral cholangiocarcinoma

ONE WEEK TO DEBUT AND I CANT WAIT ANY LONGER! ( ˶ˆᗜˆ˵ ) Officially revealing it'll be a subathon for a good cause with 50% of all of my October revenue being donated to the Cholangiocarcinoma Foundation Australia! ♡ #vtuber #vtuberdebut #vtuberuprisings

And yet another...'suddenly'😪💔 *William “Bill” Broadway-47-USA *Beloved Officer with the Huntersville Police Department, N.C. *August 20, 2025 *Tragically, William died after less than a 2-year battle with rare Stage 4 Cholangiocarcinoma, a Bile Duct Cancer. *Diagnosed in